デフォルト表紙
市場調査レポート
商品コード
1470553

避妊薬市場:製品、性別、方法、流通別-2024~2030年の世界予測

Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
避妊薬市場:製品、性別、方法、流通別-2024~2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

避妊薬市場規模は2023年に484億3,000万米ドルと推定され、2024年には548億7,000万米ドルに達し、CAGR 13.82%で2030年には1,198億9,000万米ドルに達すると予測されています。

避妊薬は避妊法としても知られ、妊娠を予防するために使用される方法や器具です。これらの製品や器具は、卵子の受精を阻害したり、受精卵が子宮に着床するのを防いだり、ホルモン周期を調節したりと、さまざまな働きをします。避妊の可能性と選択肢は、いつ、どのような場合に子どもを持ちたいかを計画する能力を個人に与え、女性と家族の健康状態の改善に貢献します。性の健康と避妊薬に関する意識を高めるための教育キャンペーンや政府の取り組みが増加したことで、様々な避妊薬の方法の採用が増加しました。さらに、新興国では医療サービスや家族計画へのアクセスが向上し、避妊薬の使用が増加しています。より効率的でユーザーフレンドリーな選択肢につながる避妊薬法の革新も、市場の成長を後押ししています。しかし、厳しい規制の枠組みは製品の承認や発売を遅らせる可能性があります。地域によっては、伝統的な信仰や宗教的制約による抵抗が、市場に課題をもたらすこともあります。とはいえ、環境意識の高い消費者に対応するため、生分解性で環境に優しい避妊薬製品を研究することは、市場成長の好機となることが期待されます。さらに、男性避妊法の新興国市場の開拓は、まもなく市場の成長を後押しする可能性があります。

主要市場の統計
基準年[2023年] 484億3,000万米ドル
予測年[2024年] 548億7,000万米ドル
予測年[2030年] 1,198億9,000万米ドル
CAGR(%) 13.82%

製品:使いやすさと非侵襲性により、避妊薬医薬品への傾向が高い

コンドームは、避妊と性感染症(STI)予防の両方を提供する避妊のバリア法として広く使用されています。コンドームは通常、ラテックス、ポリウレタン、またはラムスキン製で、一度使用したら廃棄するように設計されています。ダイアフラムは、シリコン製またはラテックス製の浅いドーム型のカップで、膣腔に挿入して子宮頸部を覆い、精子が卵子に到達するのを阻止します。ダイアフラムにはさまざまなサイズがあり、適切な使用と最大限の保護を保証するために、医療プロバイダーが装着する必要があります。銅製IUDのような子宮内避妊器具(IUD)は、少量の銅を子宮内に放出し、精子にとって有毒な環境を作ります。ホルモン性IUDは、プロゲスチンというホルモンを放出し、子宮頸管粘液を濃くして精子が卵子に到達するのを防ぎ、排卵を抑制することもあります。皮下インプラントは、上腕の下に挿入する小さな棒状の器具で、排卵を防ぐ黄体ホルモンを持続的に放出します。ヌーバリングなどの膣リングは、膣に挿入する柔軟なプラスチック製のリングで、エストロゲンとプロゲスチンの両方を放出し、1ヵ月間妊娠を予防します。注射用避妊薬は、毎日の避妊薬ピルの代わりとして、3ヶ月に一度、医療専門家によってプロゲスチンの注射が行われます。経口避妊薬(OCP)は、最も一般的な避妊方法で、エストロゲンとプロゲスチンの最適な効果を得るための様々な処方があります。経皮パッチは、皮膚に貼るホルモン剤で、黄体ホルモンとエストロゲンを血流に放出し、効果的に避妊をコントロールします。

性別:幅広い製品が入手可能なため、女性の避妊薬の採用が多いです。

女性の避妊薬は、女性が意図しない妊娠を防ぐことを目的とした多様な製品で構成されています。これらの方法には、経口ピル、注射剤、パッチなどのホルモン性避妊薬や、ホルモン性と銅ベースの子宮内避妊器具(IUD)が含まれます。ダイアフラム、子宮頸管キャップ、女性用コンドームを含む避妊薬法も、緊急用避妊薬ピルや卵管結紮のような永久的な解決法と並んで、利用可能な選択肢に貢献しています。最も一般的な男性の避妊薬は、コンドームとパイプカット(永久的な外科手術)です。しかし、男性避妊のセグメントでは、精子の生産を一時的に抑制することを目的としたホルモン性のジェルや注射など、有望な開発が進んでいます。さらに、精管内で物理的なバリアとして作用する可逆的精子誘導阻害法(RISUG)や、米国ではVasalgelとして知られる同様の方法など、非ホルモン法の研究も広がっています。男性の避妊薬の受容と人気は、文化的態度、家族計画における責任の認識、使用の利便性に影響されます。

方法:性行為中に物理的・化学的バリアを提供するバリア避妊法への嗜好の高まり

バリア避妊法は、精子が卵子に到達するのを防ぐことによって機能します。これには、男性用と女性用のコンドーム、ダイアフラム、子宮頸管キャップ、避妊薬スポンジなどがあり、性行為中に物理的または化学的なバリアを記載しています。男性用コンドームは、入手しやすく使いやすいため、最も広く使われているバリア法です。妊娠を防ぐだけでなく、さまざまな性感染症(STI)のリスクを減らすのにも効果的です。バリア方式は、使用者のホルモンに全身的な影響を与えないことから、しばしば好まれています。エストロゲンとプロゲステロンの天然ホルモンを模倣した合成ホルモンが含まれており、排卵を防いだり、子宮頸管粘液を濃くしたり、子宮内膜を変化させたりして妊娠を防ぎます。経口ピル、パッチ、注射、膣リング、子宮内避妊器具(IUD)など、さまざまな種類があります。ホルモン法の有効性は、使用法を厳守するかどうかにかかっています。その他の特典としては、月経周期が整う、月経痛が軽減する、特定の生殖器がんのリスクが減少するなどがあります。滅菌チューブは、女性の場合は卵管結紮(らんかんけっさつ)、男性の場合は精管結紮(せいかんけっさつ)、精管閉塞(せいかんへいそく)する医療処置によって実現する永久的な避妊法です。この手術は非常に効果的で、失敗する率は非常に低く、将来幼児が欲しくないと確信している人に最適です。女性の不妊手術は通常、男性の不妊手術よりも複雑で、大きなリスクを伴います。どちらの手術もほとんどの場合不可逆的であり、不妊手術を考えている人は、この避妊薬の方法が永久的なものであることをカウンセリングされるべきです。手術による避妊は、最終的に不妊につながる処置を指し、この用語は言及された不妊方法と重複するかもしれないが、手術という要素を強調しています。女性の場合は、伝統的な卵管結紮術と、腹腔鏡下で卵管に閉塞器具を装着するような最近の手術の両方が含まれます。男性の場合は、精管を切断して密閉する精管切除術があります。これらの永久的な手術は、慎重な検討とインフォームド・コンセントが必要です。

流通:年中無休のオンライン薬局による製品流通の強化

eコマースの台頭により、オンライン・プラットフォームを通じて避妊薬の入手可能性が拡大しました。このようなデジタルマーケットプレースにより、消費者は避妊薬をバラバラで便利に購入することができ、身近な地域では手に入らないような様々な製品にアクセスすることができます。クリニックは避妊薬の主要な流通チャネルであり、特に避妊用ピル、IUD、注射薬など処方箋や診察が必要な製品に適しています。これらの医療施設は、個人のニーズに最も適した避妊薬の方法について、医療専門家から個人的なアドバイスや指導を受ける機会を記載しています。クリニックは、大きな医療機関と提携している場合もあれば、独立して運営されている場合もあり、多くの場合、性と生殖に関する健康に焦点を当てています。クリニックはしばしば公衆衛生の取り組みと連携し、恵まれない人々に手ごろな価格で、あるいは無料で避妊薬を提供しています。一方、プライマリー・ヘルス・センター、コミュニティ・ヘルス・センター、州エイズ・コントロール協会、その他多くのものを含む政府のネットワークは、低所得層や医療へのアクセスが限られている地域を対象に、避妊薬を多くの場合、低価格または無料で配布しています。これらのネットワークは、公衆衛生の取り組みにおいて重要な役割を担っており、避妊薬をより多くの人々が利用できるようにするために役立っています。さらに、産後や中絶後の避妊薬にすぐにアクセスできる病院薬局は、避妊薬の流通ネットワークに不可欠です。リプロダクティブ・ヘルスや家族計画の専門部門を持つ病院は、そのような製品をより必要としている可能性があります。病院薬局は、入院中に医療従事者から直接勧められ、守秘義務を求める患者にとって重要なアクセスポイントです。さらに、独立系薬局とチェーン薬局は、避妊薬のアクセスの異なる側面に対応した価値あるサービスを提供しています。独立系薬局は個別ケアと地域との一体化に重点を置き、チェーン薬局は価格競合と利便性に優れています。独立系薬局は、地域コミュニティにおける消費者の声や嗜好に合わせて、専門的な化合物や様々なオプションを提供しています。しかし、チェーン薬局の製品ラインナップは店舗によって標準化されていることが多く、特定のブランドや製剤を求める消費者の選択肢を狭めている可能性があります。さらに、避妊用ピルのような避妊薬の定期購入サービスは人気が高まっており、補充プロセスを自動化することで服薬アドヒアランスを向上させることができます。

地域別洞察

南北アメリカの避妊薬市場は、認知度が高く、大手製薬会社が存在感を示す成熟した市場です。この地域の特徴は、避妊ピル、IUD、インプラント、コンドームなど、幅広い避妊薬メソッドがあることです。米国とカナダの政府政策と非営利団体は、特に若年層と低所得層に利用しやすい避妊法を提供する上で重要な役割を果たしています。ラテンアメリカ市場は、10代の妊娠を減らし、避妊薬の入手可能性を高めることを目的とした公衆衛生上の取り組みに後押しされ、成長を経験しています。欧州、中東、アフリカ地域では、避妊薬の状況は様々です。欧州は、避妊薬の普及率が高く、様々な避妊薬の方法を低価格または無料で提供する政府の医療システムに支えられた、確立された市場です。IUDのような長時間作用型の可逆的避妊法(LARC)に強い傾向があります。中東では対照的に、文化的・宗教的要因が避妊薬の使用に影響を与えており、国によって利用しやすさや社会的受容の程度に差があります。アフリカ大陸は避妊薬普及率が最も低く、国際援助や女性の健康問題に対する政府の関心の高まりによって、家族計画サービスの必要性が高まっています。アジア太平洋は、文化的、社会的、規制的要因に大きく影響され、多様な避妊薬市場を示しています。人口の多い国々が存在し、避妊薬の使用に関する政府の取り組みや啓蒙キャンペーンがこの地域の市場成長を促進しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは避妊薬市場の評価において極めて重要です。事業戦略や製品満足度に関する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、避妊薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発とイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.避妊薬市場の市場規模と予測は?

2.避妊薬市場の予測期間中に投資を検討すべき製品、用途は何か?

3.避妊薬市場の技術動向と規制枠組みは?

4.避妊薬市場における主要ベンダーの市場シェアは?

5.避妊薬市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 性的な健康と家族計画に関する意識の向上
      • 避妊薬ピルの使用と提供を奨励するための政府の支援策
    • 抑制要因
      • 避妊薬製品による健康への悪影響
    • 機会
      • 広範囲な研究開発による手頃な価格の避妊薬方式の採用
      • オンライン流通チャネルを通じた避妊具の入手可能性
    • 課題
      • 避妊薬の使用に関する社会的懸念と製品マーケティングの問題
  • 市場セグメンテーション分析
    • 製品:使いやすさと非侵襲性のため、避妊薬薬剤に対する高い傾向
    • 性別:幅広い製品が利用できるため、女性用避妊具の採用が大幅に増加している
    • 方法:性行為中に物理的と化学的バリアを提供するバリア避妊法の好感度が高まっている
    • 流通:オンライン薬局の24時間365日のサービスにより、製品の流通が強化
  • 市場動向分析
    • 避妊薬方法の大幅な進歩と、南北アメリカ全体で避妊を促進する政府と非政府による取り組みの増加
    • 避妊薬の認知度を高めるための政府の強力な支援と、アジア太平洋での製品プロファイルを拡大するための広範な研究開発活動
    • 家族計画と性教育を促進する政府の取り組みが増加し、欧州、中東、アフリカ全体で避妊薬手法が継続的に進歩
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制枠組みの分析

第6章 避妊薬市場:製品別

  • イントロダクション
  • 装置
  • 薬剤

第7章 避妊薬市場:性別

  • イントロダクション
  • 女性
  • 男性

第8章 避妊薬市場:方法別

  • イントロダクション
  • バリア
  • ハーモナル

第9章 避妊薬市場:流通別

  • イントロダクション
  • チェーン薬局
  • クリニック
  • 政府ネットワーク
  • 病院薬局
  • 独立系薬局
  • オンラインプラットフォーム

第10章 南北アメリカの避妊薬市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋の避妊薬市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの避妊薬市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析

第14章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTRACEPTIVE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CONDOMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CONDOMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COPPER IUDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COPPER IUDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVE PILLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVE PATCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVE PATCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HARMONAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HARMONAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GOVERNMENT NETWORK, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GOVERNMENT NETWORK, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 267. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 282. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 295. TAIWAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. TAIWAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 309. THAILAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. THAILAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 317. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 318. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 323. VIETNAM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. VIETNAM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 326. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 329. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 330. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 331. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 332. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 333. VIETNAM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 334. VIETNAM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 335. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 336. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 338. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 339. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 345. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 346. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 353. DENMARK CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 354. DENMARK CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 355. DENMARK CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 356. DENMARK CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 357. DENMARK CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 358. DENMARK CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 359. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 360. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 361. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 362. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 363. DENMARK CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 364. DENMARK CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 365. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 366. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 367. EGYPT CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 368. EGYPT CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 369. EGYPT CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 370. EGYPT CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 371. EGYPT CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 372. EGYPT CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 373. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 374. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 375. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
  • TABLE 376. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
  • TABLE 377. EGYPT CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 378. EGYPT CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 379. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 380. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 381. FINLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 382. FINLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 383. FINLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 384. FINLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 385. FINLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
  • TABLE 386. FINLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
  • TABLE 387. FINLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
目次
Product Code: MRR-4316E4E895C4

[192 Pages Report] The Contraceptive Market size was estimated at USD 48.43 billion in 2023 and expected to reach USD 54.87 billion in 2024, at a CAGR 13.82% to reach USD 119.89 billion by 2030.

Contraceptives, also known as birth control, are methods or devices used to prevent pregnancy. These products or practices can work in various ways, such as inhibiting the fertilization of an egg, preventing the implantation of a fertilized egg in the uterus, or regulating hormonal cycles. The availability and choice of contraception provide individuals with the ability to plan if and when they want to have children, contributing to better health outcomes for women and families. Increased educational campaigns and government initiatives to raise awareness about sexual health and contraceptives have increased the adoption of various contraceptive methods. Further, enhanced access to healthcare services and family planning in emerging economies has increased the use of contraceptives. Innovations in contraceptive methods leading to more efficient and user-friendly options also bolstered the market growth. However, strict regulatory frameworks can delay product approvals and launches. Resistance in certain regions due to traditional beliefs and religious constraints may pose challenges for the market. Nevertheless, investigating biodegradable and eco-friendly contraceptive products to cater to environmentally conscious consumers is expected to provide an opportunistic way for market growth. Moreover, developments in male contraception methods may bolster the market growth shortly.

KEY MARKET STATISTICS
Base Year [2023] USD 48.43 billion
Estimated Year [2024] USD 54.87 billion
Forecast Year [2030] USD 119.89 billion
CAGR (%) 13.82%

Product: High inclination toward contraceptive drugs due to their ease of use and non-invasiveness

Condoms are a widely used barrier method of contraception that provides both birth control and protection against sexually transmitted infections (STIs). Condoms are usually made of latex, polyurethane, or lambskin and are designed to be used once and disposed of after use. The diaphragm is a shallow, dome-shaped cup made of silicone or latex that is inserted into the vaginal cavity to cover the cervix and block sperm from reaching the ovum. Diaphragms are available in various sizes, and a healthcare provider must fit them to ensure proper use and maximum protection. Intrauterine devices (IUDs) such as Copper IUDs release a small amount of copper into the uterus, which creates a toxic environment for sperm. Hormonal IUDs release progestin, a hormone that thickens the cervical mucus to prevent sperm flow from reaching the egg and sometimes suppresses ovulation. Subdermal implants are small, rod-shaped devices inserted below the upper arm, releasing a continuous amount of progestin hormone to prevent ovulation. Vaginal rings, such as the NuvaRing, are flexible plastic rings that are inserted into the vagina and release both estrogen and progestin to offer month-long pregnancy protection. Injectable contraceptives are injections of progestin given by a healthcare professional every three months as an alternative to daily contraceptive pills. Oral contraceptive pills (OCPs) are the most common methods of contraception, available in various formulations of estrogen and progestin for optimal effectiveness. The transdermal patch is a hormonal contraceptive applied to the skin, releasing progestin and estrogen into the bloodstream to effectively control contraception.

Gender: Significant adoption of female contraceptives due to availability of a wide range of products

The female contraceptive comprises a diverse range of products aimed at enabling women to prevent unintended pregnancies. These methods include hormonal contraceptives such as oral contraceptive pills, injectables, and patches, as well as intrauterine devices (IUDs), both hormonal and copper-based. Contraceptive methods, including diaphragms, cervical caps, and female condoms, also contribute to the options available, alongside emergency contraceptive pills and permanent solutions such as tubal ligation. The most common male contraceptives include condoms and vasectomy, a permanent surgical procedure. However, there are promising developments in the field of male contraception, such as hormonal gels and injections that aim to inhibit sperm production temporarily. Furthermore, research into non-hormonal methods, including the reversible inhibition of sperm under guidance (RISUG) and a similar method in the U.S. known as Vasalgel, which acts as a physical barrier inside the vas deferens, is expanding. The acceptance and popularity of male contraceptives are influenced by cultural attitudes, perceived responsibility in family planning, and the convenience of use.

Method: Rising preference for barrier methods of contraception that provide a physical and chemical barrier during sexual activities

Barrier methods of contraception work by preventing the sperm from reaching the egg. These include male and female condoms, diaphragms, cervical caps, and contraceptive sponges, providing a physical or chemical barrier during sexual activities. Male condoms are the most widely used barrier method as they are readily available and easy to use. In addition to preventing pregnancy, these are effective in reducing the risk of various sexually transmitted infections (STIs). Barrier methods are often favored for their lack of systemic effects on the user's hormones. Hormonal contraceptives contain synthetic hormones that mimic estrogen and progesterone's natural hormones to prevent ovulation, thicken cervical mucus, or alter the uterine lining to prevent pregnancy. These types come in various forms, including oral pills, patches, injections, vaginal rings, and intrauterine devices (IUDs). The effectiveness of hormonal methods depends on strict adherence to their usage regimen. Additionally, these methods can offer benefits such as regulated menstrual cycles, reduced menstrual cramps, and a decreased risk of certain reproductive cancers. Sterilization is a permanent form of birth control achieved through medical procedures that close or block the fallopian tubes in females (tubal ligation) or the vas deferens in males (vasectomy). The procedures are highly effective with a very low rate of failure and are best suited for individuals who are sure they do not want children in the future. Female sterilization is usually more complex and carries greater risks than male sterilization, which is often a simpler outpatient procedure. Both procedures are irreversible in most cases, and individuals considering sterilization should be counseled on the permanent nature of this contraceptive method. Surgical contraception refers to procedures that ultimately lead to sterilization, and while the term may overlap with sterilization methods mentioned, it emphasizes the factor of surgery. For women, this includes both traditional tubal ligation and more recent procedures, such as the laparoscopic placement of occlusive devices on the fallopian tubes. For men, vasectomy involves the cutting and sealing of the vas deferens. These permanent procedures require careful consideration and informed consent, as reversal attempts may not be successful and are often costly.

Distribution Channel: Enhanced product distribution through online pharmacies due to their 24/7 services

The rise of eCommerce has expanded the availability of contraceptives through online platforms. These digital marketplaces allow consumers to purchase contraceptives discretely and conveniently, providing access to various products that may not be available in their immediate geographical area. Clinics serve as a primary distribution channel for contraceptives, particularly for forms requiring prescription or medical consultation, such as birth control pills, IUDs, and injectables. These healthcare facilities provide an opportunity for individuals to receive personalized advice and guidance from health professionals about the most appropriate contraceptive method for their needs. Clinics may be affiliated with larger healthcare institutions or operate independently, often focusing on sexual and reproductive health. They often work in conjunction with public health initiatives to provide affordable or free contraceptives to underprivileged populations. On the other hand, Government networks, including Primary Health Centers, Community Health Centers, State AIDS Control Societies, and many others, distribute contraceptives often at reduced or no cost, targeting lower-income brackets and regions with limited access to healthcare. These networks have a crucial role in public health initiatives and are instrumental in making contraceptives accessible to a broader audience. Further, hospital pharmacies are integral to the distribution network for contraceptives as they provide immediate access to postpartum and post-abortion contraceptives. Hospitals with specialized reproductive health or family planning divisions may need such products more. Hospital pharmacies are an important access point for patients seeking confidentiality and direct recommendations from healthcare providers during their hospital stay. Furthermore, independent and chain pharmacies offer valuable services catering to different aspects of contraceptive access. Independents focus on personalized care and community integration, while chains excel in price competitiveness and convenience. Independent pharmacies offer specialized compounds and a range of options tailored to consumer feedback and preferences in their local community. However, chain pharmacy product range is often standardized across locations, potentially limiting options for consumers seeking specific brands or formulations. Moreover, subscription services for contraceptives, such as birth control pills, have become increasingly popular and can improve adherence by automating the refill process.

Regional Insights

The contraceptive market in the Americas presents a mature landscape with high awareness levels and a strong presence of major pharmaceutical companies. The region is characterized by a wide range of contraceptive methods including birth control pills, IUDs, implants, and condoms. Government policies and non-profit organizations in the United States and Canada play a crucial role in providing accessible contraception, particularly to younger and lower-income populations. The Latin American market is experiencing growth, propelled by public health initiatives aimed at reducing teenage pregnancies and increasing the availability of contraceptives. The EMEA region presents a varying landscape for contraceptives. Europe has a well-established market with high contraceptive prevalence rates, backed by governmental healthcare systems that offer various contraceptive methods at low or no cost. There is a strong tendency toward long-acting reversible contraceptives (LARCs) such as IUDs. The Middle East, contrastingly, has cultural and religious factors that influence contraceptive use, with varying degrees of accessibility and societal acceptance across different countries. The African continent shows the lowest contraceptive prevalence rate and is experiencing a rise in need for family planning services, driven by international aid, and increasing government focus on women's health issues. The Asia-Pacific region showcases a diverse contraceptive market, heavily influenced by cultural, social, and regulatory factors. The presence of high-population countries coupled with government initiatives and awareness campaigns for the use of contraceptives has propelled the market growth in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Contraceptive Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contraceptive Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, ASKA Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Bayer AG, Church & Dwight Co., Inc., HLL Lifecare Limited, Insud Pharma, S.L., Johnson & Johnson Services, Inc., Lupin Limited, Mayne Pharma Group Limited, Merck & Co., Inc., Mithra Pharmaceuticals S.A., Okamoto Industries, Inc., Organon & Co., Perrigo Company plc, Pfizer Inc., Piramal Pharma Ltd., Reckitt Benckiser Group plc, RITEX GMBH, Sanofi S.A., Say It With A Condom, LLC., Syzygy Healthcare Solutions LLC, Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., TTK Healthcare Limited, Veru Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Contraceptive Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Devices
      • Condoms
      • Diaphragm
      • IUDs
        • Copper IUDs
        • Hormonal IUDs
      • Subdermal Implants
      • Vaginal Rings
    • Drugs
      • Injectables
      • Oral Contraceptive Pills
      • Transdermal Contraceptive Patch
  • Gender
    • Female Contraceptive
    • Male Contraceptive
  • Method
    • Barrier
    • Harmonal
  • Distribution
    • Chain Pharmacy
    • Clinics
    • Government Network
    • Hospital Pharmacy
    • Independent Pharmacy
    • Online Platform
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Contraceptive Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contraceptive Market?

3. What are the technology trends and regulatory frameworks in the Contraceptive Market?

4. What is the market share of the leading vendors in the Contraceptive Market?

5. Which modes and strategic moves are suitable for entering the Contraceptive Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased awareness regarding sexual health and family planning
      • 5.1.1.2. Supportive government initiatives to encourage use and provision of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of contraceptive products
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of affordable contraceptive methods with extensive R&D
      • 5.1.3.2. Availability of contraceptives through online distribution channels
    • 5.1.4. Challenges
      • 5.1.4.1. Social concerns regarding contraceptive usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: High inclination toward contraceptive drugs due to their ease of use and non-invasiveness
    • 5.2.2. Gender: Significant adoption of female contraceptives due to availability of a wide range of products
    • 5.2.3. Method: Rising preference for barrier methods of contraception that provide a physical and chemical barrier during sexual activities
    • 5.2.4. Distribution Channel: Enhanced product distribution through online pharmacies due to their 24/7 services
  • 5.3. Market Trend Analysis
    • 5.3.1. Significant advancements in contraceptive methods coupled with increasing government and non-government initiatives to promote contraceptives across the Americas
    • 5.3.2. Strong government support to spread awareness of contraceptives and extensive R&D activities to expand product profiles in APAC
    • 5.3.3. Increasing government initiatives promoting family planning and sexual health education, with ongoing advancements in contraceptive methods across EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Contraceptive Market, by Product

  • 6.1. Introduction
  • 6.2. Devices
  • 6.3. Drugs

7. Contraceptive Market, by Gender

  • 7.1. Introduction
  • 7.2. Female Contraceptive
  • 7.3. Male Contraceptive

8. Contraceptive Market, by Method

  • 8.1. Introduction
  • 8.2. Barrier
  • 8.3. Harmonal

9. Contraceptive Market, by Distribution

  • 9.1. Introduction
  • 9.2. Chain Pharmacy
  • 9.3. Clinics
  • 9.4. Government Network
  • 9.5. Hospital Pharmacy
  • 9.6. Independent Pharmacy
  • 9.7. Online Platform

10. Americas Contraceptive Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Contraceptive Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Contraceptive Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Richmond Biotech Company to buy Contraceptive biz for USD 100 Million
    • 13.3.2. UK Launches First Trial of Hormone-free Male Birth Control pill
    • 13.3.3. Aditxt Acquires Phexxi Contraceptive Gel-Maker Evofem for USD 100 million
    • 13.3.4. Dare Bioscience Launches Phase III Hormone-free Contraceptive Trial
    • 13.3.5. Lupin Launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the United States
    • 13.3.6. Bayer and CrossBay Medical to Develop Novel Intrauterine System Inserter
    • 13.3.7. Xiromed LLC Announces Launch of EnilloRing in the United States
    • 13.3.8. Bayer Invests in USD 267.2 Million new Production Facility in Finland to Accelerate Global Access to Modern Contraception
    • 13.3.9. NIH Center Grant Bolsters Male Contraceptive Research
    • 13.3.10. Gates Foundation, Children's Investment Fund Foundation, Pfizer and BD Company Expand Partnership for Greater Access to Injectable Contraceptive for Women
    • 13.3.11. Perrigo Announces U.S. FDA Approval for Opill OTC Daily Oral Contraceptive
    • 13.3.12. FDA Approves First Nonprescription Daily Oral Contraceptive
    • 13.3.13. Sirona Acquires India's First Vegan Condom Brand Bleu

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio